| Home : April 2020 : April 06, 2020 News : Kymab Racing for a U.S. IPO Listing in 3rd Quarter of 2020. |
Kymab Racing for a U.S. IPO Listing in 3rd Quarter of 2020. |
April 06, 2020
Based in Cambridgeshire, Kymab is discovering and developing human monoclonal antibody therapeutics with an initial focus on malaria and HIV.
1888PressRelease - Led by CEO Simon Sturge, the pharmaceutical company has raised over £200m over seven funding rounds. Investors include LifeArc, Malin Corporation and Wellcome Trust, along with Woodford Investment Man [...]
https://www.1888pressrelease.com/kymab-racing-for-a-u-s-ipo-listing-in-3rd-quarter-of-2020-pr-672847.html
|
|
|
 Other Stories |
|
|
|
|
|
|
|
|
|
|
|
